Archive for September, 2008

Use of eHiTS CrossDocking Approaches to Survey the Ligand/Target Landscape

Monday, September 29th, 2008

<meta content="OpenOffice.org 2.0 (Linux)" name="GENERATOR" /><meta content="20080929;4451400" name="CREATED" /><meta content="20080929;10390700" name="CHANGED" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0in">Virtual high throughput screening requires the use of approximate approaches to distinguish the complimentarity of ligands to target. Often this falls to the domain of 2D approaches such as fingerprint, topological, and shape screens, given the computational efficiency of such approaches. High throughput docking, employing the 3D structures of ligand and targets, however, provides a facile first approach to glean principles for ligand recognition of targets. The endpoint might be screening a database against a single target to determine which ligands are plausible lead compounds to be explored with other computational approaches (e.g. free energy computation and estimation of binding free energies) or recommendation for synthesis or testing <em>in vitro</em> high throughput assays. Alternatively, one might wish to know how such compounds ’score’ against an array of targets that one <u>doesn’t</u> want to “hit” with a novel lead candidate. Such an approach may be important in eliminating unwanted side-effects/toxicity</p> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in">Before using eHiTS for such a screening enterprise, it is useful to perform a benchmark crossdocking screen using a set of crystal structures of ligand-receptor complexes. Each of the ‘native’ ligands extracted from each of the co-complexes is then docked against the panel of other targets. The matrix below shows an example of such a hypothetical screen to examine how each of the native ligands of 13 targets score against targets in the same or distinct pharmacological families. Each cell entry corresponds to the eHiTS docking score of the ligand extracted from the top row complex against the target extracted from the left column complex. The diagonal elements (bold-font) show the best docking score for (self docking of) each ligand against its own crystal structure target. The blue font entries in each column illustrate that while quite (most) often the ‘native ligand’ for a target crystal structure is amongst the best scoring (within 1-2 eHiTS scoring units) it is not always the best score. Quite often ‘native’ ligands for other targets will have significant affinity for your target of interest (and will plausibly have good eHiTS docking scores) and this is both the challenge of drug design in attempts to control specificity and selectivity for a panorama of target proteins/receptors.</p> <p align="justify" style="margin-bottom: 0in"><img align="middle" alt="Table 1" title="Table 1" src="http://simbiosys.ca/blog/images/Table.jpg" /></p> <p align="justify" style="margin-bottom: 0in">One is looking for several facets in such a preliminary screen. One expects that each of the native ligands found in a co-complex crystal structure of course does dock to the native target. One expects, in most instances, that the docking score for each native ligand for its ‘natural’ target will be near the minimum score compared to other ligands (typically within a few scoring units). The figures below shows in what portion of the cases the native ligand is among the best N scoring ligands. It is of course possible that ‘native’ ligands derived from other target complexes will score well against your target of interest, but that kind of ‘crosstalk’ is precisely the type of information that one wants to glean from such a low cost computer ‘experiment.’ One also wants to know how use of different crystal structures with alternative conformations of binding site residues affects the docking scores. While a docking score is not a binding free energy, eHiTS docking scores often give at least monotonic score correlations with lnKd’s in instances where the scoring function calibration has included interaction types of the nature of your target of interest.</p> <p align="justify" style="margin-bottom: 0in"><img align="middle" src="http://simbiosys.ca/blog/images/PIECHART.jpg" /></p> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in"><meta content="text/html; charset=utf-8" http-equiv="CONTENT-TYPE" /><title /><meta content="OpenOffice.org 2.0 (Linux)" name="GENERATOR" /><meta content="20080929;4451400" name="CREATED" /><meta content="20080929;10390700" name="CHANGED" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in"><img align="middle" src="http://simbiosys.ca/blog/images/CUMULATIVE.jpg" /></p> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in">What about the timescale for such screens? For eHiTS 6.2 on Intel platforms versus the new Lighting release? In a recent benchmark I found it to be ~3.5 minutes/ligand (using 4-Xeon 3.2GHz nodes) versus an average of 30 seconds per ligand on Cell processor in a Sony Playstation 3 (PS3). Note that this corresponds to docking at the highest accuracy. For screening of large libraries of molecules, a lower level of accuracy is recommended with a typical docking time of less than 10 seconds per ligand on the PS3.</p> <p align="justify" style="margin-bottom: 0in"> <p align="justify" style="margin-bottom: 0in">While the timescale of such 3D approaches has not been competitive with 2D methods, the advances in porting eHiTS to the Cell will make this approach feasible for high throughput analysis with quantitative estimation of both docking-score/IC50 correlations and accurate pose prediction.</p> <p align="justify" style="margin-bottom: 0in"> <p style="margin-bottom: 0in">Blog post by Dan Harris</p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/science/" title="View all posts in Science" rel="category tag">Science</a>, <a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="View all posts in tips and hints" rel="category tag">tips and hints</a> | <a href="http://www.simbiosys.com/blog/2008/09/29/use-of-ehits-crossdocking-approaches-to-survey-the-ligandtarget-landscape/#respond" title="Comment on Use of eHiTS CrossDocking Approaches to Survey the Ligand/Target Landscape">No Comments »</a></p> </div> <div class="post"> <h3 id="post-46"><a href="http://www.simbiosys.com/blog/2008/09/02/orr-ravitz-joined-simbiosys/" rel="bookmark" title="Permanent Link to Orr Ravitz joined SimBioSys">Orr Ravitz joined SimBioSys</a></h3> <small>Tuesday, September 2nd, 2008</small> <div class="entry"> <p><meta http-equiv="CONTENT-TYPE" content="text/html; charset=utf-8" /><title /><meta name="GENERATOR" content="OpenOffice.org 2.4 (Unix)" /> <style type="text/css"> <!-- @page { size: 8.5in 11in; margin: 0.79in } P { margin-bottom: 0.08in } --> </style></p> <p style="margin-bottom: 0in"><font size="2" style="font-size: 11pt">Hi,</font></p> <p style="margin-bottom: 0in"><font size="2" style="font-size: 11pt">Allow me to Introduce myself. My name is Orr Ravitz, and I recently joined SimBioSys as an applications scientist. I was fortunate to join the company in a time of significant developments: in the next few months we will launch improved versions of our drug discovery tools, eHiTS, eHiTS Lightning, and LASSO, we are in the process of introducing to the market our unique synthetic route designer, ARChem, and we also have several innovative scientific concepts in the pipeline. The fact that this is happening while the pharmaceutical industry is undergoing dramatic restructuring, offers SimBioSys an opportunity to make a huge impact on the process of drug discovery and drug development.</font></p> <p style="margin-bottom: 0in"><font size="2" style="font-size: 11pt"><br /> My professional path has been, in a sense, a small-scale analogy to the evolution of computational chemistry as many of us envision it. I started in basic research, working with pen and paper on mathematical problems in quantum dynamics. I then switched to applying computational quantum methods to study spectral tuning mechanisms in rhodopsin, and rhodopsin isoforms. And in my current incarnation, I am participating in the grand endeavour of developing and delivering tools for computer aided drug design. This gradual transition from working on scientific problems from a pure academic perspective, to working on scientific products with very concrete applications is both intriguing and challenging.</font></p> <p style="margin-bottom: 0in"><font size="2" style="font-size: 11pt">It is no secret that we are in trying times for the pharmaceutical industry. In spite of tremendous amounts of public and private money spent on R&D, we see very few new drugs entering the market each year. It may be argued that this is partly because of the business models of the pharmaceutical companies, but, to a large extent, this is a genuine manifestation for our (much) less-than-perfect ability to translate our scientific knowledge, understanding and capabilities to practical solutions to acute problems. This is where SimBioSys plays a crucial role.</font></p> <p style="margin-bottom: 0in"><font size="2" style="font-size: 11pt">SimBioSys is providing cutting edge solutions (see picture below)<img alt="Orr provides cutting edge solutions - as a fire fighter" title="Orr provides cutting edge solutions - as a fire fighter" src="http://www.simbiosys.ca/images/orr_blog_photo.jpg" /> </font></p> <p style="margin-bottom: 0in"><font size="2" style="font-size: 11pt">to reduce the costs and enhance the capabilities of drug discovery and drug development. I strongly believe that computational tools are going to become an increasingly dominant means to improve the scientific and financial performance of pharmaceutical companies. SimBioSys, with a team that offers a well balanced combination of computer scientists and chemists, is in a position to become one of the leaders in the area. I hope to be able to add my own perspective to this group of talented people, and I further hope to maintain an open dialogue with our clients, and with people of the chemistry community and learn how SimBioSys can better serve the noble cause of finding cures for diseases and improving the well being of people.</font></p> <p style="margin-bottom: 0in">posted by Orr </p> </div> <p class="postmetadata">Posted in <a href="http://www.simbiosys.com/blog/category/general-discussion/" title="View all posts in General Discussion" rel="category tag">General Discussion</a>, <a href="http://www.simbiosys.com/blog/category/news/" title="View all posts in News" rel="category tag">News</a> | <a href="http://www.simbiosys.com/blog/2008/09/02/orr-ravitz-joined-simbiosys/#respond" title="Comment on Orr Ravitz joined SimBioSys">No Comments »</a></p> </div> <div class="navigation"> <div class="alignleft"></div> <div class="alignright"></div> </div> </div> <div id="sidebar"> <ul> <li> <a href="http://www.simbiosys.com"><img src="images/SimBioSysLogo_name_long.gif" width="200" ></a> </li> <li> <form method="get" id="searchform" action="http://www.simbiosys.com/blog/"> <div><input type="text" value="" name="s" id="s" /> <input type="submit" id="searchsubmit" value="Search" /> </div> </form> </li> <li> <form style="border:1px solid #ccc;padding:3px;text-align:center;" action="http://www.feedburner.com/fb/a/emailverify" method="post" target="popupwindow" onsubmit="window.open('http://www.feedburner.com/fb/a/emailverifySubmit?feedId=1550225', 'popupwindow', 'scrollbars=yes,width=550,height=520');return true"><p>Enter your email address:</p><p><input type="text" style="width:140px" name="email"/></p><input type="hidden" value="http://feeds.feedburner.com/~e?ffid=1550225" name="url"/><input type="hidden" value="SimBioSys Blog" name="title"/><input type="hidden" name="loc" value="en_US"/><input type="submit" value="Subscribe" /><p>Delivered by <a href="http://www.feedburner.com" target="_blank">FeedBurner</a></p></form> </li> <!-- Author information is disabled per default. Uncomment and fill in your details if you want to use it. <li><h2>Author</h2> <p>A little something about you, the author. Nothing lengthy, just an overview.</p> </li> --> <li> <p>You are currently browsing the <a href="http://www.simbiosys.com/blog/">SimBioSys Blog</a> weblog archives for September, 2008.</p> </li> <li class="pagenav"><h2>Pages</h2><ul><li class="page_item"><a href="http://www.simbiosys.com/blog/about/" title="About SimBioSys">About SimBioSys</a></li> </ul></li> <li><h2>Archives</h2> <ul> <li><a href='http://www.simbiosys.com/blog/2012/01/' title='January 2012'>January 2012</a></li> <li><a href='http://www.simbiosys.com/blog/2011/12/' title='December 2011'>December 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/11/' title='November 2011'>November 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/09/' title='September 2011'>September 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/08/' title='August 2011'>August 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/04/' title='April 2011'>April 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/03/' title='March 2011'>March 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2011/01/' title='January 2011'>January 2011</a></li> <li><a href='http://www.simbiosys.com/blog/2010/10/' title='October 2010'>October 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/09/' title='September 2010'>September 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/08/' title='August 2010'>August 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/07/' title='July 2010'>July 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/06/' title='June 2010'>June 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/03/' title='March 2010'>March 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2010/01/' title='January 2010'>January 2010</a></li> <li><a href='http://www.simbiosys.com/blog/2009/12/' title='December 2009'>December 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/11/' title='November 2009'>November 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/10/' title='October 2009'>October 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/07/' title='July 2009'>July 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/06/' title='June 2009'>June 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/05/' title='May 2009'>May 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/03/' title='March 2009'>March 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/02/' title='February 2009'>February 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2009/01/' title='January 2009'>January 2009</a></li> <li><a href='http://www.simbiosys.com/blog/2008/12/' title='December 2008'>December 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/11/' title='November 2008'>November 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/10/' title='October 2008'>October 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/09/' title='September 2008'>September 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/08/' title='August 2008'>August 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/07/' title='July 2008'>July 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/06/' title='June 2008'>June 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/05/' title='May 2008'>May 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/04/' title='April 2008'>April 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/03/' title='March 2008'>March 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/02/' title='February 2008'>February 2008</a></li> <li><a href='http://www.simbiosys.com/blog/2008/01/' title='January 2008'>January 2008</a></li> </ul> </li> <li><h2>Categories</h2> <ul> <li><a href="http://www.simbiosys.com/blog/category/general-discussion/" title="View all posts filed under General Discussion">General Discussion</a> (22) </li> <li><a href="http://www.simbiosys.com/blog/category/news/" title="View all posts filed under News">News</a> (64) </li> <li><a href="http://www.simbiosys.com/blog/category/science/" title="View all posts filed under Science">Science</a> (42) </li> <li><a href="http://www.simbiosys.com/blog/category/software-products/" title="View all posts filed under Software products">Software products</a> (38) </li> <li><a href="http://www.simbiosys.com/blog/category/technology/" title="View all posts filed under Technology">Technology</a> (21) </li> <li><a href="http://www.simbiosys.com/blog/category/science/tips-and-hints/" title="Tells us tips and hints on how to best use eHiTS, and other SimBioSys tools, to maximize your ROI (return on invested time, money, energy etc.). It’s a must-read!">tips and hints</a> (5) </li> </ul> </li> </ul> </div> <hr /> <div id="footer"> <!-- If you'd like to support WordPress, having the "powered by" link someone on your blog is the best way, it's our only promotion or advertising. --> <p> SimBioSys Blog is proudly powered by <a href="http://wordpress.org/">WordPress</a> <br /><a href="feed:http://www.simbiosys.com/blog/feed/">Entries (RSS)</a> and <a href="feed:http://www.simbiosys.com/blog/comments/feed/">Comments (RSS)</a>. <!-- 17 queries. 0.219 seconds. --> </p> </div> </div> <!-- Gorgeous design by Michael Heilemann - http://binarybonsai.com/kubrick/ --> </body> </html>